drugset / Trial / NCT07557680

Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients

NCT07557680

Phase 3 Completed 70 enrolled Sindh Institute of Urology and Transplantation
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized control trial, which was carried out at Sindh Institute of Urology and Transplantation (SIUT), used a non-probability consecutive sampling technique for six months from January 1, 2025, to June 30, 2025.

Timeline

Start
2025-01-01
Primary completion
2025-06-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications